Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69747bdec522c2b149071d3b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sodium Chloride Inhalation Solution USP 3% w/v",
"description": "SODICHLOR 3% is a sterile, preservative-free hypertonic saline inhalation solution specifically formulated to help manage respiratory conditions characterized by thick, tenacious mucus secretions. This pharmaceutical-grade formulation contains 3% sodium chloride in purified water, offering a concentration three times higher than normal saline, designed to work through osmotic principles to improve airway clearance and respiratory function.\nAs a trusted therapeutic agent in respiratory care, SODICHLOR 3% represents a non-antibiotic approach to managing chronic respiratory conditions, making it an invaluable tool for patients suffering from cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and other conditions where mucus clearance is compromised. The solution is administered via nebulization, allowing the medication to reach deep into the bronchial passages where it can exert its therapeutic effects most effectively.\nHow SODICHLOR 3% Works\nThe mechanism of action behind SODICHLOR 3% is elegantly simple yet highly effective. When nebulized and inhaled, the hypertonic saline solution creates an osmotic gradient in the airways. This means that the higher salt concentration in the solution draws water from the surrounding tissues into the airway surface liquid layer. This influx of water hydrates the mucus, making it less viscous and sticky, which significantly improves the ability to cough up and clear secretions from the lungs.\nAdditionally, SODICHLOR 3% helps restore the normal salt and water balance on airway surfaces, which is particularly important in conditions like cystic fibrosis where this balance is naturally disrupted. The solution also stimulates ciliary beat frequency, enhancing the natural cleaning mechanism of the respiratory tract. By improving mucociliary clearance, SODICHLOR 3% helps reduce the bacterial burden in the airways, potentially decreasing the frequency of respiratory infections and exacerbations.\nPrimary Uses and Applications\nSODICHLOR 3% is prescribed for various respiratory conditions where enhanced mucus clearance is clinically beneficial:\nCystic Fibrosis Management: Perhaps the most well-established use, SODICHLOR 3% has become a cornerstone therapy for patients with cystic fibrosis. Regular use helps thin the abnormally thick mucus characteristic of this genetic condition, improving lung function and quality of life while reducing the risk of pulmonary exacerbations.\nChronic Obstructive Pulmonary Disease: For COPD patients who struggle with excessive mucus production and poor clearance, SODICHLOR 3% provides relief by facilitating easier expectoration and improving breathing comfort.\nBronchiectasis: This condition, characterized by permanently damaged and widened airways that trap mucus, benefits significantly from hypertonic saline therapy. SODICHLOR 3% helps clear the pooled secretions that contribute to recurrent infections.\nPost-Operative Respiratory Care: Following certain surgical procedures, particularly thoracic surgeries, SODICHLOR 3% may be used to prevent mucus plugging and atelectasis by maintaining adequate airway hydration.\nSputum Induction: In diagnostic settings, SODICHLOR 3% can be used to induce sputum production for laboratory testing when patients cannot spontaneously produce adequate samples.\nKey Benefits of SODICHLOR 3%\nThe therapeutic advantages of SODICHLOR 3% extend across multiple dimensions of respiratory health:\nEnhanced Mucus Clearance: The primary benefit is the dramatic improvement in the ability to clear thick, sticky mucus from the airways. Patients often report easier breathing and more productive coughing within minutes of treatment.\nImproved Lung Function: Clinical studies have demonstrated that regular use of hypertonic saline solutions like SODICHLOR 3% can lead to measurable improvements in pulmonary function tests, including forced expiratory volume (FEV1) and forced vital capacity (FVC).\nReduced Infection Frequency: By promoting better mucus clearance and reducing bacterial colonization in the airways, SODICHLOR 3% may help decrease the frequency of respiratory infections and disease exacerbations, leading to fewer hospitalizations.\nNon-Antibiotic Therapy: In an era of increasing antibiotic resistance, SODICHLOR 3% offers a mechanical rather than chemical approach to managing respiratory symptoms, making it a valuable addition to any treatment regimen without contributing to resistance patterns.\nCost-Effective Treatment: Compared to many specialized respiratory medications, SODICHLOR 3% represents a relatively affordable therapeutic option that can be used long-term without prohibitive expense.\nQuality of Life Enhancement: Patients using SODICHLOR 3% regularly often report significant improvements in their daily activities, exercise tolerance, and overall sense of well-being due to easier breathing and reduced respiratory distress.\nCompatibility with Other Treatments: SODICHLOR 3% can be safely used alongside other respiratory medications, including bronchodilators, corticosteroids, and antibiotics, as part of a comprehensive treatment plan.\nPotential Side Effects and Considerations\nWhile SODICHLOR 3% is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects: The most frequently reported adverse effects include throat irritation, coughing (especially initially), unpleasant taste, and mild wheezing or chest tightness. These effects are typically transient and often diminish with continued use as the body adapts to the therapy.\nBronchospasm: Some patients, particularly those with hyperreactive airways or asthma, may experience bronchospasm (sudden narrowing of the airways) during or after treatment. This is why healthcare providers often recommend using a bronchodilator before SODICHLOR 3% administration.\nTemporary Oxygen Desaturation: In some cases, especially in patients with severe lung disease, temporary decreases in blood oxygen levels may occur immediately after treatment, though levels typically return to baseline within 30 minutes.\nNasal Congestion and Rhinorrhea: Some patients may experience nasal stuffiness or runny nose following inhalation therapy.\nLess Common Effects: Headache, nausea, dizziness, or voice changes may occasionally occur but are generally mild and self-limiting.\nPatients with certain conditions such as uncontrolled hypertension, severe electrolyte imbalances, or recent hemoptysis should use SODICHLOR 3% only under close medical supervision. As with any medical treatment, it's essential to discuss your complete medical history with your healthcare provider before beginning therapy.\nConclusion\nSODICHLOR 3% represents a scientifically sound, clinically proven approach to managing respiratory conditions complicated by thick mucus secretions. Its mechanism of action—leveraging osmotic principles to hydrate and mobilize airway secretions—addresses a fundamental problem faced by millions of patients with chronic respiratory diseases. The substantial body of evidence supporting its efficacy, combined with its favorable safety profile and cost-effectiveness, makes SODICHLOR 3% an indispensable component of modern respiratory care.",
"price": 540.0,
"discountamount": 162.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2283,
"imageuri": "https://productimages.withfloats.com/actual/69747be5cf228670cde34180.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69747be5cf228670cde34180.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-01-24T07:59:26.118Z",
"updatedon": "2026-03-14T07:09:16.685Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/sodium-chloride-inhalation-solution-usp-3-w-v/2283",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SODICHLOR 3%",
"category": "ASTHMARANGE",
"tags": [
"sodium chloride inhalation solution usp 3 percent",
"sodium chloride 3% nebulizer solution",
"sodium chloride 3% respiratory solution",
"sodium chloride inhalation solution usp 3% price",
"buy sodium chloride 3% inhalation solution",
"sodium chloride 3% nebulizer solution manufacturer",
"sodium chloride inhalation solution usp 3% benefits",
"sodium chloride inhalation solution usp 3% benefits",
"sodium chloride inhalation solution usp 3% dosage",
"sodium chloride inhalation solution usp 3% side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6912fc8c470ec71b0ac87646",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "mometasone furoate formoterol fumarate inhaler",
"description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.",
"price": 360.0,
"discountamount": 108.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2199,
"imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-11-11T09:06:20.511Z",
"updatedon": "2026-03-14T08:49:38.354Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mometasone-furoate-formoterol-fumarate-inhaler/2199",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MONTASENSE F INH",
"category": "ASTHMA RANGE",
"tags": [
"Mometasone Furoate and Formoterol Fumarate Inhaler",
"respiratory medication",
"chronic obstructive pulmonary disease (COPD)",
"muscles of the airways.",
"respiratory control in one inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler for asthma treatment",
"Mometasone Furoate Formoterol Fumarate dosage guide",
"Mometasone Furoate Formoterol Fumarate inhaler side effects",
"Best time to use Mometasone Furoate Formoterol Fumarate inhaler",
"Buy Mometasone Furoate Formoterol Fumarate inhaler online",
"Mometasone Furoate Formoterol Fumarate inhaler price per unit",
"Where to purchase Mometasone Furoate Formoterol Fumarate inhaler",
"Mometasone Furoate Formoterol Fumarate inhaler buy at the best price"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6864fe81c4418d1ebb0d08eb",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Dry powder inhaler",
"description": "The STERIS DPI DEVICE is a modern, user-friendly Dry Powder Inhaler (DPI) designed to deliver respiratory medication directly to the lungs in a highly efficient and portable form. Inhalation therapy plays a critical role in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The DPI device simplifies this process by delivering the drug in the form of a dry powder without the need for coordination between actuation and inhalation, making it ideal for patients of all ages.\n\nWhat is a DPI Device?\nA Dry Powder Inhaler (DPI) is a medical device used to deliver therapeutic medication directly into the lungs. Unlike traditional inhalers that use propellants to push the drug into the lungs, DPI devices rely on the patient’s own inhalation power to disperse and inhale the powdered drug effectively. Essentially, a DPI device is a tool that administers medication in dry powder form to the lungs, providing quick and targeted respiratory relief.\n\nDPI Full Form: Dry Powder Inhaler\n\nUses of STERIS DPI DEVICE\nThe STERIS DPI DEVICE is commonly used in the treatment and management of respiratory diseases such as:\n\nAsthma\n\nChronic Obstructive Pulmonary Disease (COPD)\n\nBronchitis\n\nAllergic airway conditions\n\nIt helps deliver medication directly to the airways, ensuring faster action and reduced systemic side effects compared to oral treatments.\n\nHow It Works\nWhen the patient inhales through the mouthpiece, the device uses the airflow to disperse the dry powder into fine particles, allowing it to reach deep into the lungs. The inhaled medication begins working quickly to open airways, reduce inflammation, or treat infection, depending on the formulation used with the DPI.\n\nSide Effects of Dry Powder Inhaler Use\nWhile the STERIS DPI DEVICE itself is safe and user-friendly, some medications delivered via DPI may cause minor side effects such as:\n\nDry throat or mouth\n\nHoarseness\n\nCough\n\nIrritation in the throat\n\nFungal infections in the mouth (if corticosteroids are used and mouth is not rinsed after use)\n\nThese side effects can often be minimized with proper usage and hygiene.\n\nPrecautions Before Using STERIS DPI DEVICE\nAlways read the instructions carefully before first-time use.\n\nMake sure the device is clean and free from moisture.\n\nInhale deeply and forcefully to ensure proper medication delivery.\n\nDo not exhale into the device, as moisture can affect the powder's consistency.\n\nStore in a dry, cool place away from direct sunlight.\n\nAlways rinse your mouth after using corticosteroid-based powders.\n\nAdvantages of STERIS DPI DEVICE\nPropellant-free and eco-friendly\n\nPortable and compact design for daily use\n\nNo coordination required between inhalation and actuation\n\nDelivers medication effectively with minimal effort\n\nEasy-to-use, even for elderly or pediatric patients\n\nConclusion\nThe STERIS DPI DEVICE is a highly effective solution for individuals suffering from chronic or acute respiratory disorders. By delivering medication directly to the lungs in a dry powder form, it ensures fast relief, greater bioavailability, and improved patient compliance. Whether you’re managing asthma or COPD, this DPI device offers a dependable and convenient way to breathe easier every day.",
"price": 255.0,
"discountamount": 77.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"coordination required",
"inhalation power",
"inhalation making",
"breathe easier",
"individuals suffering",
"compact design",
"ecofriendly portable",
"direct sunlight",
"instructions carefully",
"hygiene precautions",
"proper usage",
"medications delivered",
"reach deep",
"oral treatments",
"critical role",
"medical device",
"patient inhales",
"administers medication",
"highly efficient",
"respiratory diseases",
"dpi device",
"dry throat",
"dry powder",
"side effects",
"moisture inhale deeply",
"delivering medication directly",
"lungs providing quick",
"dry powder form",
"chronic respiratory conditions",
"pediatric patients conclusion",
"dpi device offers",
"dpi device simplifies",
"steris dpi device",
"dpi side effects",
"youre managing asthma",
"dry powder inhaler",
"minor side effects",
"improved patient compliance",
"highly effective solution",
"throat fungal infections",
"dry cool place",
"acute respiratory disorders",
"minimal effort easytouse",
"corticosteroidbased powders advantages",
"powders consistency store",
"treat infection depending",
"fine particles allowing"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2142,
"imageuri": "https://productimages.withfloats.com/actual/6864feb4c75fa610aeaeaeda.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6864feb4c75fa610aeaeaeda.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-02T09:40:17.078Z",
"updatedon": "2026-05-20T07:52:29.086Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dry-powder-inhaler/2142",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "STERIS DPI DEVICE",
"category": "RESPIRTORYRANGE",
"tags": [
"Dry powder inhaler",
"pulmonary disease (COPD)",
"respiratory symptoms",
"Asthma",
"Asthma or COPD Patients",
"How does a dry powder inhaler work",
"Dry powder inhaler vs metered dose inhaler difference",
"How to use a dry powder inhaler correctly",
"How to use a dry powder inhaler correctly",
"Dry powder inhaler for asthma treatment",
"Dry powder inhaler for COPD patients",
"Types of dry powder inhaler devices",
"Buy dry powder inhaler online",
"Dry powder inhaler price comparison",
"Best dry powder inhaler for asthma",
"dry powder inhaler capsule",
"dry powder inhaler capsule device",
"formoterol dry powder inhaler capsule",
"dry powder inhaler capsule steps",
"dry powder inhaler capsule how to use",
"dry powder inhaler capsule device steps",
"dry powder inhaler capsule device open",
"dry powder inhaler capsule formulations",
"dry powder inhaler capsule loading",
"dry powder inhaler capsule device india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6863d70eaf0c9d1aa0c2d3e5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "fluticasone furoate and vilanterol powder for inhalation",
"description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.",
"price": 740.0,
"discountamount": 222.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"12 years",
"24 hours",
"increased risk",
"drugs interact",
"antiviral medications",
"recommended dose",
"airways open",
"reduce inflammation",
"acute asthma",
"asthma attacks",
"severe asthma",
"copd attacks",
"inhaler consistently",
"optimal results",
"breathing comfort",
"longacting bronchodilation",
"antiinflammatory power",
"inhaled corticosteroids",
"vilanterol antifungal",
"tricyclic antidepressants",
"taking betablockers",
"prescribed inform",
"tuberculosis rinse",
"headache hoarseness",
"initial phase",
"generally welltolerated",
"fluticatone vilo 200",
"exercise capacity",
"emphysema reduces",
"chronic bronchitis",
"relaxing muscles",
"rescue medicine",
"vilanterol relaxes",
"prevent symptoms",
"specially formulated",
"vilanterol 25 mcg",
"vilanterol powder",
"rare effects",
"ketoconazole ritonavir",
"healthcare provider",
"therapy common",
"potent corticosteroid",
"fluticasone furoate",
"side effects",
"lung function",
"vilanterol fluticasone furoate",
"copd exacerbations improves",
"inhalation fluticasone furoate",
"lung function quality",
"fixeddose inhalation powder",
"increase corticosteroid levels",
"fastacting inhaler inform",
"combination inhalation therapy",
"side effects consult",
"frequent side effects",
"inhalation longterm treatment",
"healthcare providers guidance",
"ritonavir itraconazole leading",
"highly effective corticosteroid",
"effective oncedaily treatment",
"heart rhythm disturbances",
"strong cyp3a4 inhibitors",
"hypokalemia mao inhibitors",
"atenolol propranolol diuretics",
"breastfeeding drug interactions",
"pregnant planning pregnancy",
"avoid oral thrush",
"sore throat cough",
"adolescents maintenance treatment",
"longterm maintenance treatment",
"prescription combination medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2140,
"imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png",
"tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-01T12:39:42.59Z",
"updatedon": "2026-03-14T08:43:22.38Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//fluticasone-furoate-and-vilanterol-powder-for-inhalation/2140",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "FLUTICATONE VILO 200",
"category": "ASTHMARANGE",
"tags": [
"fluticasone furoate and vilanterol powder for inhalation",
"chronic obstructive pulmonary disease",
"lung function",
"Fluticasone Furoate and Vilanterol Powder",
"emphysema."
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66d99766d075bc6e1b960947",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "glycopyrrolate glycopyrronium inhalation solution 25 mcg",
"description": "GLYCOPRESS \nglycopyrrolate glycopyrronium inhalation solution 25 mcg \nGLYCOPRESS™ is a precision-formulated inhalation solution containing 25 mcg of glycopyrrolate (also known as glycopyrronium), a long-acting bronchodilator designed to help individuals manage chronic respiratory conditions. Glycopyrrolate belongs to a class of medications known as long-acting muscarinic antagonists (LAMAs). These medicines work by relaxing the muscles surrounding the airways, allowing them to remain open for easier breathing.\n\nGLYCOPRESS™ is primarily prescribed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is intended for regular, long-term use and is delivered via a nebulizer system, ensuring consistent and controlled medication delivery directly into the lungs.\n\nThis inhalation solution is developed to provide sustained bronchodilation, improved airflow, and enhanced respiratory comfort for patients who require ongoing airway management.\n\nHow GLYCOPRESS™ Works\n\nThe active ingredient in GLYCOPRESS™, glycopyrrolate, works by blocking the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle. Acetylcholine is a neurotransmitter that causes airway muscles to constrict. By inhibiting its action, glycopyrrolate helps prevent bronchospasm (tightening of the airway muscles).\n\nThis mechanism results in:\n\nRelaxation of bronchial smooth muscles\n\nReduced airway resistance\n\nImproved airflow\n\nEasier breathing\n\nAs a long-acting bronchodilator, GLYCOPRESS™ provides sustained airway dilation, making it suitable for daily maintenance therapy rather than immediate relief of sudden breathing problems.\n\nIndications and Uses\n\nGLYCOPRESS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nManagement of chronic bronchitis\n\nManagement of emphysema\n\nLong-term bronchodilation therapy\n\nIt is important to note that GLYCOPRESS™ is not a rescue medication. It should not be used for sudden episodes of shortness of breath. Patients should continue to carry a fast-acting rescue inhaler for acute bronchospasm episodes.\n\nKey Benefits of GLYCOPRESS™\n1. Long-Lasting Bronchodilation\n\nGLYCOPRESS™ provides sustained airway relaxation, helping maintain open airways throughout the day when used as prescribed.\n\n2. Improved Breathing Comfort\n\nBy reducing airway constriction, patients often experience reduced shortness of breath, wheezing, and chest tightness.\n\n3. Enhanced Lung Function\n\nRegular use may lead to measurable improvements in lung capacity and airflow over time.\n\n4. Reduced Exacerbations\n\nConsistent bronchodilation can help lower the frequency and severity of COPD flare-ups.\n\n5. Convenient Nebulized Delivery\n\nThe inhalation solution format ensures medication reaches deep into the lungs, especially beneficial for patients who struggle with handheld inhalers.\n\n6. Targeted Action\n\nBecause the medication is inhaled directly into the lungs, systemic exposure is minimized compared to oral medications, potentially reducing widespread side effects.\n\n7. Non-Steroidal Option\n\nGLYCOPRESS™ does not contain corticosteroids, making it suitable for patients seeking bronchodilation without steroid exposure.\n\nDosage and Administration\n\nGLYCOPRESS™ (25 mcg) should be used exactly as prescribed by a healthcare professional. The inhalation solution is administered via a standard nebulizer device.\n\nGeneral usage guidelines:\n\nUse at the same time each day.\n\nDo not exceed the prescribed dose.\n\nDo not swallow the solution.\n\nRinse the mouth after inhalation if advised by your healthcare provider.\n\nClean the nebulizer equipment after each use to maintain hygiene and prevent contamination.\n\nPatients should never abruptly discontinue therapy without consulting their healthcare provider.\n\nPossible Side Effects\n\nLike all medications, GLYCOPRESS™ may cause side effects. While many patients tolerate glycopyrrolate well, some may experience mild to moderate reactions.\n\nCommon Side Effects\n\nDry mouth\n\nThroat irritation\n\nCough\n\nHeadache\n\nNasal congestion\n\nMild dizziness\n\nThese effects are usually manageable and may decrease as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nDifficulty urinating\n\nBlurred vision\n\nIncreased heart rate (tachycardia)\n\nWorsening of glaucoma symptoms\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nPatients with a history of narrow-angle glaucoma, urinary retention, or prostate enlargement should use GLYCOPRESS™ with caution and under medical supervision.\n\nIf sudden worsening of breathing occurs immediately after use (paradoxical bronchospasm), discontinue the medication and seek medical attention immediately.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS™, inform your healthcare provider if you:\n\nHave glaucoma\n\nHave urinary retention issues\n\nHave prostate enlargement\n\nHave kidney problems\n\nAre pregnant or breastfeeding\n\nAre using other anticholinergic medications\n\nDrug interactions may occur when used alongside other anticholinergic drugs, potentially increasing side effects such as dry mouth or urinary retention.\n\nGLYCOPRESS™ should be stored at room temperature and kept away from direct sunlight and moisture. Keep out of reach of children.\n\nWho Should Use GLYCOPRESS™?\n\nGLYCOPRESS™ is suitable for adults diagnosed with chronic obstructive pulmonary disease who require consistent, long-term airway management. It is particularly beneficial for:\n\nPatients who experience persistent daily symptoms\n\nIndividuals who require nebulized medication delivery\n\nPatients needing a non-steroidal maintenance bronchodilator\n\nThose seeking improved respiratory stability and quality of life\n\nIt is not recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nQuality and Reliability\n\nGLYCOPRESS™ is manufactured under strict pharmaceutical quality standards to ensure consistent dosing accuracy, sterility, and safety. Each 25 mcg dose is carefully formulated to deliver precise bronchodilation while minimizing systemic absorption.\n\nIts inhalation solution format ensures even dispersion and efficient lung deposition when used with an appropriate nebulizer system.\n\nLifestyle Support with GLYCOPRESS™\n\nWhile GLYCOPRESS™ plays a critical role in COPD management, optimal results are achieved when combined with:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular exercise as advised\n\nBalanced nutrition\n\nRoutine medical follow-up\nPatients are encouraged to monitor symptoms regularly and maintain open communication with their healthcare provider.\nConclusion\nGLYCOPRESS™ (Glycopyrrolate / Glycopyrronium Inhalation Solution 25 mcg) represents a reliable, long-acting bronchodilator option for individuals managing chronic obstructive pulmonary disease. By targeting airway muscle constriction at its source, GLYCOPRESS™ promotes sustained bronchodilation, improved airflow, and enhanced breathing comfort.",
"price": 2250.0,
"discountamount": 675.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"2 ml",
"1 ml",
"25 mcg",
"Dry Mouth",
"single dose",
"fast relief",
"gut motility",
"higher doses",
"stomach acid",
"Key Benefits",
"clear airways",
"long-term use",
"bodily fluids",
"natural fluids",
"rare instances",
"potential risks",
"fast heart rate",
"mucus production",
"Preoperative Use",
"saliva production",
"Glycopyrrolate IP",
"Urinary Retention",
"clinical settings",
"saliva substitutes",
"specific condition",
"healthcare provider",
"common side effects",
"respiratory diseases",
"muscarinic receptors",
"glandular secretions",
"Respiratory Function",
"excessive secretions",
"Increased Heart Rate",
"optimal effectiveness",
"2ml isotonic solution",
"Isotonic solution 2ml",
"respiratory conditions",
"Convenient Dosage Form",
"anticholinergic effects",
"intramuscular injection",
"healthcare professional",
"other bodily secretions",
"effective administration",
"Temporary blurred vision",
"various medical conditions",
"specialized pharmaceutical solution"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1970,
"imageuri": "https://productimages.withfloats.com/actual/66d99795d84b3a29c4a85529.png",
"tileimageuri": "https://productimages.withfloats.com/tile/66d99795d84b3a29c4a85529.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-09-05T11:35:02.018Z",
"updatedon": "2026-04-08T09:01:49.567Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glycopyrrolate-glycopyrronium-inhalation-solution-25-mcg/1970",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLYCOPRESS ",
"category": "ASTHMARANGE",
"tags": [
"glycopyrrolate glycopyrronium inhalation solution 25 mcg single dose vial",
"glycopyrrolate glycopyrronium 25 mcg nebulizer solution for COPD",
"glycopyrrolate 25 mcg inhalation solution unit dose ampule",
"glycopyrrolate 25 mcg nebulized bronchodilator therapy",
"glycopyrrolate inhalation 25 mcg dosing instructions",
"glycopyrrolate 25 mcg inhalation solution prescribing information",
"what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for",
"what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for",
"is glycopyrronium 25 mcg inhalation solution safe for COPD",
"can glycopyrrolate 25 mcg inhalation solution cause dry mouth",
"buy glycopyrrolate glycopyrronium inhalation solution 25 mcg online"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6661a57d8da3a81d5c6a17dd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Mycophenolate mofetil 500mg",
"description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n",
"price": 775.0,
"discountamount": 256.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"part",
"Call",
"harm",
"risk",
"Email",
"heart",
"ORDER",
"nausea",
"kidney",
"dosage",
"doctor",
"vomiting",
"WhatsApp",
"Patients",
"diarrhea",
"rejection",
"infections",
"500mg dose",
"combination",
"information",
"sterisonline",
"proliferation",
"B lymphocytes",
"abdominal pain",
"pregnant women",
"immune response",
"developing fetus",
"other medications",
"liver transplants",
"other complications",
"healthcare provider",
"Common side effects",
"organ transplantation",
"Mycophenolate mofetil",
"immunosuppressive drug",
"Mycoplasm M 500 therapy",
"healthcare professional",
"other immunosuppressants",
"immunosuppressive effects",
"potential adverse effects",
"optimal therapeutic outcomes",
"gastrointestinal disturbances",
"comprehensive transplant treatment regimen"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1472,
"imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T12:03:09.216Z",
"updatedon": "2026-03-12T08:00:39.14Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "MYCOPLASM M 500",
"category": "NEPHROLOGYRANGE",
"tags": [
"MYCOPLASM M 500",
"Mycophenolate mofetil (500mg)",
"Mycophenolate mofetil 500 mg tablet",
"Mycophenolate mofetil 500 mg price",
"Mycophenolate mofetil 500 mg dosage",
"Mycophenolate mofetil uses",
"Mycophenolate mofetil side effects",
"mycophenolate mofetil 500mg tablet uses",
"mycophenolate mofetil 500mg dosage for kidney transplant",
"mycophenolate mofetil 500mg for autoimmune disease"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "66603e93ea22b014e8af1574",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "salmeterol fluticasone",
"description": "INH AIRFLOW 250 \nBreathing freely is something most people take for granted—until conditions like asthma or chronic obstructive pulmonary disease (COPD) make every breath a struggle. Long-term respiratory diseases require consistent, preventive treatment rather than short-term relief alone. This is where INH AIRFLOW 250, a combination of salmeterol and fluticasone, plays a vital role.\n\nINH AIRFLOW 250 is a trusted inhalation therapy designed to provide dual action control—relaxing the airways while reducing inflammation at its source. It is widely prescribed for patients who need daily maintenance therapy to keep respiratory symptoms under control and prevent frequent attacks.\n\nComposition of INH AIRFLOW 250\n\nEach dose of INH AIRFLOW 250 contains:\n\nSalmeterol – a long-acting bronchodilator (LABA)\n\nFluticasone – a corticosteroid (anti-inflammatory agent)\n\nThis powerful combination addresses both airway constriction and chronic inflammation, making it more effective than single-drug inhalers.\n\nHow INH AIRFLOW 250 Works (Mechanism of Action)\nRole of Salmeterol\n\nSalmeterol is a long-acting beta-2 agonist that works by:\n\nRelaxing the muscles around the airways\n\nKeeping bronchial passages open for up to 12 hours\n\nPreventing bronchospasm (airway tightening)\n\nUnlike short-acting inhalers used during sudden attacks, salmeterol is meant for long-term control, not emergency relief.\n\nRole of Fluticasone\n\nFluticasone is a corticosteroid that:\n\nReduces inflammation inside the airways\n\nDecreases swelling and mucus production\n\nPrevents airway sensitivity and irritation\n\nTogether, salmeterol and fluticasone provide round-the-clock protection by treating both the symptoms and the underlying cause of airway disease.\n\nUses of INH AIRFLOW 250\n\nINH AIRFLOW 250 is prescribed for the long-term management of chronic respiratory conditions, including:\n\n1. Asthma\n\nModerate to severe persistent asthma\n\nPatients whose asthma is not controlled by inhaled corticosteroids alone\n\nPrevention of nighttime asthma symptoms\n\nReduction in frequency and severity of asthma attacks\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nChronic bronchitis\n\nEmphysema\n\nPrevention of COPD exacerbations\n\nImprovement in lung function and exercise tolerance\n\nImportant: INH AIRFLOW 250 is not a rescue inhaler and should not be used for sudden breathing emergencies.\n\nWho Should Use INH AIRFLOW 250?\n\nINH AIRFLOW 250 is suitable for:\n\nAdults and adolescents (as advised by a physician)\n\nPatients with frequent wheezing, coughing, or breathlessness\n\nIndividuals needing daily maintenance inhalation therapy\n\nPatients experiencing nighttime or exercise-induced symptoms\n\nHow to Use INH AIRFLOW 250 Correctly\n\nProper inhaler technique is essential for maximum benefit.\n\nGeneral Usage Guidelines\n\nUse exactly as prescribed by your doctor\n\nUsually taken twice daily (morning and evening)\n\nDo not exceed the recommended dose\n\nRinse your mouth with water after each use\n\nCorrect usage ensures the medicine reaches deep into the lungs and reduces the risk of side effects.\n\nKey Benefits of INH AIRFLOW 250\n1. Dual Action Formula\n\nCombines a bronchodilator and a steroid for comprehensive control.\n\n2. Long-Lasting Symptom Relief\n\nProvides up to 12 hours of airway relaxation and inflammation control.\n\n3. Reduced Frequency of Attacks\n\nHelps prevent asthma and COPD flare-ups when used regularly.\n\n4. Improved Quality of Life\n\nAllows patients to:\n\nBreathe more comfortably\n\nSleep better at night\n\nPerform daily activities with ease\n\n5. Preventive Rather Than Reactive\n\nTreats the root cause instead of only relieving symptoms temporarily.\n\n6. Lower Steroid Requirement\n\nCombination therapy reduces the need for higher steroid doses.\n\nSide Effects of INH AIRFLOW 250\n\nLike all medicines, INH AIRFLOW 250 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHoarseness of voice\n\nThroat irritation\n\nCough after inhalation\n\nHeadache\n\nMild oral fungal infection (thrush)\n\nRinsing the mouth after inhalation significantly reduces the risk of oral infections.\n\nLess Common but Important Side Effects\n\nPalpitations or fast heartbeat\n\nTremors\n\nMuscle cramps\n\nIncreased risk of respiratory infections\n\nRare but Serious Side Effects\n\nSevere allergic reactions\n\nWorsening breathing symptoms\n\nLong-term high-dose steroid effects (with improper use)\n\nSeek medical attention if symptoms worsen instead of improving.\n\nPrecautions and Warnings\n\nNot meant for sudden asthma attacks\n\nDo not stop abruptly without consulting your doctor\n\nUse with caution in patients with heart disease\n\nInform your doctor if you have tuberculosis, fungal infections, or diabetes\n\nPregnant or breastfeeding women should use only if prescribed\n\nWhy INH AIRFLOW 250 Is a Preferred Choice\n\nWhat makes INH AIRFLOW 250 stand out is its balanced formulation that delivers effective respiratory control without excessive medication exposure. It supports long-term lung health while minimizing daily symptom burden.\n\nDoctors often prefer this combination because it:\n\nImproves adherence\n\nReduces hospital visits\n\nPrevents disease progression\n\nProvides consistent symptom control\n\nStorage Instructions\n\nStore in a cool, dry place\n\nKeep away from direct sunlight\n\nKeep out of reach of children\n\nDo not puncture or expose to heat\n\nConclusion\n\nINH AIRFLOW 250 (Salmeterol + Fluticasone) is a reliable and effective inhalation therapy for individuals living with asthma or COPD. By combining long-acting bronchodilation with powerful anti-inflammatory action, it offers comprehensive, long-term respiratory control. When used correctly and consistently, INH AIRFLOW 250 helps patients breathe easier, reduce flare-ups, and regain confidence in their daily lives.\n",
"price": 532.0,
"discountamount": 160.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"Call",
"LABA",
"dose",
"COPD",
"Email",
"lungs",
"muscles",
"airways",
"WhatsApp",
"coughing",
"patients",
"wheezing",
"breathing",
"shortness",
"Salmeterol",
"INH AIRFLOW",
"information",
"Fluticasone",
"constriction",
"instructions",
"sterispharma",
"sterisonline",
"rapid relief",
"best results",
"lung function",
"corticosteroid",
"asthma attacks",
"effective relief",
"healthcare provider",
"dual-action formula",
"precise combination",
"acting beta agonist",
"personalized advice",
"long-lasting control",
"respiratory symptoms",
"respiratory conditions",
"right treatment option",
"potential side effects",
"underlying inflammation",
"powerful combination inhaler",
"comprehensive respiratory support",
"chronic obstructive pulmonary disease"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1367,
"imageuri": "https://productimages.withfloats.com/actual/69621b2add4a22deedc1989c.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/69621b2add4a22deedc1989c.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-05T10:31:47.916Z",
"updatedon": "2026-03-14T08:22:50.018Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//salmeterol-fluticasone/1367",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "INH AIRFLOW 250 ",
"category": "ASTHMARANGE",
"tags": [
"INH AIRFLOW 250",
"Salmeterol (50mg),",
"Fluticasone (250mg)",
"Salmeterol inhaler",
"fluticasone salmeterol 250/50",
"salmeterol (50mg) capsule"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6630c2b7f518ac0ce829c048",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Formoterol 6mg Budesonide 200mg",
"description": "INH BUDEPRESS 200 \nFormoterol 6mg, Budesonide 200mg\nFormoterol 6 mcg + Budesonide 200 mcg Inhalation Therapy\n\nLiving with asthma or chronic obstructive pulmonary disease (COPD) can significantly affect daily life — from limiting physical activity to causing restless nights due to breathlessness and wheezing. Effective long-term management requires a treatment approach that not only provides immediate airway relaxation but also addresses the root cause: chronic airway inflammation.\n\nINH BUDEPRESS 200 is a scientifically formulated combination inhalation therapy containing Formoterol 6 mcg and Budesonide 200 mcg, designed to deliver dual-action respiratory control. This advanced combination helps patients breathe easier, stay active, and experience fewer exacerbations when used consistently as prescribed.\n\nProduct Overview\n\nProduct Name: INH BUDEPRESS 200\nComposition per dose:\n\nFormoterol Fumarate 6 mcg\n\nBudesonide 200 mcg\nDosage Form: Inhalation (Dry Powder Inhaler or Metered Dose Inhaler as prescribed)\nTherapeutic Category: Inhaled Corticosteroid (ICS) + Long-Acting Beta2 Agonist (LABA)\n\nINH BUDEPRESS 200 is intended for maintenance therapy in patients who require both anti-inflammatory and bronchodilator support. It is not a rescue inhaler for sudden asthma attacks but a preventive treatment used regularly for sustained symptom control.\n\nHow INH BUDEPRESS 200 Works\n\nINH BUDEPRESS 200 combines two complementary medications that work together to improve lung function and reduce respiratory symptoms.\n\n1. Budesonide (200 mcg) – Anti-Inflammatory Protection\n\nBudesonide is an inhaled corticosteroid that directly targets airway inflammation — the primary cause of asthma symptoms and COPD flare-ups. Chronic inflammation leads to airway narrowing, mucus production, and increased sensitivity to triggers such as allergens, cold air, or pollution.\n\nBudesonide works by:\n\nReducing swelling in the airways\n\nDecreasing mucus production\n\nLowering immune system overreaction\n\nPreventing long-term airway damage\n\nWith regular use, budesonide helps reduce the frequency and severity of asthma attacks.\n\n2. Formoterol (6 mcg) – Long-Acting Bronchodilation\n\nFormoterol is a long-acting beta2-adrenergic agonist (LABA) that relaxes the smooth muscles surrounding the airways. Unlike some other bronchodilators, formoterol has a rapid onset of action while still providing long-lasting relief for up to 12 hours.\n\nFormoterol helps:\n\nOpen narrowed airways\n\nImprove airflow\n\nReduce wheezing and breathlessness\n\nEnhance exercise tolerance\n\nTogether, budesonide and formoterol create a powerful dual mechanism that controls both the underlying inflammation and airway constriction.\n\nUses of INH BUDEPRESS 200\n\nINH BUDEPRESS 200 is commonly prescribed for:\n\n1. Moderate to Severe Persistent Asthma\n\nPatients not adequately controlled with inhaled corticosteroids alone\n\nIndividuals experiencing frequent symptoms or nighttime awakenings\n\nPrevention of exercise-induced bronchospasm\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nChronic bronchitis\n\nEmphysema\n\nPrevention of COPD exacerbations\n\nImprovement of lung function and quality of life\n\n3. Maintenance and Preventive Therapy\n\nIt helps maintain long-term symptom stability and reduces emergency visits due to respiratory distress.\n\nKey Benefits of INH BUDEPRESS 200\nDual-Action Formula\n\nCombines anti-inflammatory and bronchodilator therapy in one inhaler for comprehensive control.\n\nRapid and Long-Lasting Relief\n\nFormoterol acts quickly while maintaining bronchodilation for up to 12 hours.\n\nReduced Frequency of Asthma Attacks\n\nRegular use decreases exacerbations and emergency interventions.\n\nImproved Lung Function\n\nEnhances airflow and improves measurable lung parameters like FEV1.\n\nBetter Nighttime Control\n\nReduces nighttime symptoms and improves sleep quality.\n\nEnhanced Daily Activity\n\nSupports improved stamina and physical activity levels.\n\nLower Steroid Exposure\n\nTargeted inhalation delivery ensures effective lung action with minimal systemic absorption compared to oral steroids.\n\nImproved Quality of Life\n\nPatients experience greater confidence in managing their respiratory condition with fewer limitations.\n\nDirections for Use\n\nUse exactly as prescribed by your healthcare provider.\n\nTypically administered twice daily.\n\nInhale deeply and steadily for proper lung deposition.\n\nRinse mouth with water after each use to reduce risk of fungal infection.\n\nDo not stop suddenly without medical advice.\n\nImportant: Always carry a fast-acting rescue inhaler for sudden breathing difficulty.\n\nPossible Side Effects\n\nWhile INH BUDEPRESS 200 is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nThroat irritation\n\nHoarseness\n\nDry mouth\n\nHeadache\n\nMild tremors\n\nCough\n\nOral Thrush (Candidiasis)\n\nBudesonide may cause fungal infection in the mouth. Rinsing after inhalation significantly reduces this risk.\n\nCardiovascular Effects\n\nFormoterol may occasionally cause:\n\nPalpitations\n\nSlight increase in heart rate\n\nMild blood pressure fluctuations\n\nMuscle Cramps or Nervousness\n\nSometimes associated with LABA medications.\n\nLess Common but Serious Side Effects\n\nSevere allergic reactions\n\nParadoxical bronchospasm (sudden worsening of breathing)\n\nAdrenal suppression with prolonged high-dose use\n\nDecreased bone density (with long-term use)\n\nSeek immediate medical help if you experience chest pain, severe shortness of breath, or facial swelling.\n\nPrecautions and Warnings\n\nNot intended for acute asthma attacks.\n\nUse cautiously in patients with heart disease, hypertension, diabetes, or thyroid disorders.\n\nInform your doctor if pregnant or breastfeeding.\n\nMonitor growth in children receiving long-term corticosteroid therapy.\n\nRegular medical follow-up is recommended to adjust dosage if needed.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight and moisture.\n\nKeep out of reach of children.\n\nWhy Choose INH BUDEPRESS 200?\n\nINH BUDEPRESS 200 offers a balanced and clinically trusted approach to respiratory management. Its carefully calibrated combination of budesonide and formoterol ensures that both inflammation and bronchoconstriction are effectively addressed.\n\nThis integrated therapy:\n\nSimplifies treatment by combining two medications in one device\n\nEnhances patient adherence\n\nProvides consistent, round-the-clock protection\n\nReduces dependency on emergency inhalers\n\nFor individuals seeking reliable maintenance therapy, INH BUDEPRESS 200 serves as a dependable option under medical supervision.\n\nConclusion\nChronic respiratory conditions such as asthma and COPD require proactive, consistent management rather than reactive treatment alone. INH BUDEPRESS 200, containing Formoterol 6 mcg and Budesonide 200 mcg, offers a comprehensive dual-action solution that targets airway inflammation while ensuring sustained bronchodilation.",
"price": 352.0,
"discountamount": 106.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"6mg",
"COPD",
"250mg",
"200mg",
"breath",
"airways",
"coughing",
"wheezing",
"patients",
"shortness",
"protection",
"Formoterol",
"Budesonide",
"inhalation",
"ingredients",
"Fluticasone",
"inflammation",
"precise doses",
"lung function",
"INH BUDEPRESS",
"corticosteroid",
"convenient use",
"asthma attacks",
"reliable solution",
"acting beta agonist",
"respiratory symptoms",
"respiratory conditions",
"potent combination inhaler",
"optimal treatment outcomes",
"comprehensive respiratory care",
"chronic obstructive pulmonary disease"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 889,
"imageuri": "https://productimages.withfloats.com/actual/6630c2bbfa384161ec2c3921.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6630c2bbfa384161ec2c3921.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-30T10:06:47.377Z",
"updatedon": "2026-05-27T08:27:53.037Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//formoterol-6mg-budesonide-200mg/889",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "BUDESHINE 200 INH",
"category": "ASTHMARANGE",
"tags": [
"Formoterol 6 mcg Budesonide 200 mcg inhaler uses",
"Budesonide 200 mcg with Formoterol fumarate 6 mcg inhalation",
"200/6 mcg inhaler for moderate persistent asthma",
"Buy Formoterol 6 mcg Budesonide 200 mcg inhaler online",
"Budesonide Formoterol 200/6 inhaler best price",
"Budesonide 200 mcg Formoterol 6 mcg inhaler for long term asthma control",
"formoterol budesonide",
"formoterol budesonide inhaler",
"formoterol budesonide respules",
"glycopyrrolate formoterol budesonide inhaler",
"formoterol budesonide inhaler india",
"glycopyrrolate formoterol budesonide rotacaps",
"formoterol budesonide inhaler brands",
"formoterol budesonide brands"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad73c502f1fbe0284e2dcb5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ketorolac Tromethamine Ophthalmic Solution",
"description": "CIPVISION KEYPROFEN 0.5 is an ophthalmic formulation containing Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory drug (NSAID) used in specific eye-care situations. It works by reducing the production of prostaglandins, chemical substances that contribute to pain and inflammation. This action may help manage certain inflammatory eye symptoms when the medicine is prescribed for an appropriate condition.\n\nCIPVISION KEYPROFEN 0.5 is intended for topical application to the eyes under the supervision of a qualified healthcare professional. Its suitability depends on the patient's symptoms, clinical diagnosis, and the approved product information.\n\nFor pharmacies, medical distributors, healthcare professionals, and pharmaceutical product catalogues, CIPVISION KEYPROFEN 0.5 represents an ophthalmic product containing a recognised anti-inflammatory ingredient. Appropriate product information helps users understand its intended role, administration requirements, and important precautions.\nComposition of CIPVISION KEYPROFEN 0.5\nThe stated active ingredient in CIPVISION KEYPROFEN 0.5 is:\n\nKetorolac Tromethamine 0.5% w/v: This medicine belongs to the NSAID class. It inhibits cyclooxygenase enzymes involved in the production of prostaglandins, helping reduce inflammatory activity and associated discomfort in suitable ophthalmic conditions.\n\nThe complete formulation, inactive ingredients, pack size, and approved therapeutic indications should be verified using the product packaging and official prescribing information.\nKey Features of CIPVISION KEYPROFEN 0.5 Eye Drops\nCIPVISION KEYPROFEN 0.5 has several important characteristics relevant to ophthalmic care:\n- NSAID-based formulation: Contains Ketorolac Tromethamine, a non-steroidal anti-inflammatory medicine.\n- Inflammation control: Helps manage inflammation in specific eye conditions when prescribed appropriately.\n- Prostaglandin reduction: Acts by inhibiting enzymes involved in the formation of inflammatory mediators.\n- Topical eye application: Designed for administration directly into the eye according to prescribed directions.\n- Clinically guided use: Requires an appropriate diagnosis and advice from an eye-care professional.\nThe potential role of this medicine depends on the underlying eye condition, the approved product indications, and the patient's individual health requirements.\nWhat Is CIPVISION KEYPROFEN 0.5 Used For?\nCIPVISION KEYPROFEN 0.5 may be prescribed for selected eye conditions in which reducing inflammation, itching, or pain is clinically appropriate. The precise indication should be confirmed from the approved product information.\n1. Management of Selected Inflammatory Eye Conditions\nInflammation of the eye may cause redness, irritation, watering, and discomfort. Ketorolac Tromethamine reduces the production of prostaglandins involved in the inflammatory response. An ophthalmologist can determine whether this medicine is suitable after assessing the cause of the symptoms.\n2. Relief of Certain Types of Eye Discomfort\nKetorolac Tromethamine ophthalmic preparations may help relieve ocular pain in approved clinical situations. Some formulations are also indicated for itching associated with seasonal allergic conjunctivitis. These uses depend on the specific product's approved labelling.\n\nPersistent eye pain, redness, or irritation should not be treated through self-medication because these symptoms can arise from infections, injuries, or other conditions requiring different treatment.\n3. Eye Care Following Certain Surgical Procedures\nSome Ketorolac Tromethamine ophthalmic products are used to manage pain and inflammation associated with eye surgery, including cataract procedures. Postoperative treatment must follow the ophthalmologist's instructions because the appropriate medicine, dosage, and duration depend on the procedure and the patient's recovery.\n\nAlways verify whether CIPVISION KEYPROFEN 0.5 is approved for the intended postoperative use before including a specific surgical indication in product information.\nHow Does CIPVISION KEYPROFEN 0.5 Work?\nKetorolac Tromethamine belongs to the non-steroidal anti-inflammatory drug category. Its action involves inhibiting cyclooxygenase (COX) enzymes, which help produce prostaglandins.\n\nProstaglandins participate in inflammatory processes and pain signalling. By reducing their production, Ketorolac Tromethamine can help control inflammation and associated discomfort in certain eye conditions.\n\nUnlike corticosteroids, Ketorolac Tromethamine is a non-steroidal anti-inflammatory medicine. However, it is not appropriate for every eye complaint. It does not treat all causes of eye redness or pain, and suspected infections may require a different treatment approach.\nPotential Benefits of CIPVISION KEYPROFEN 0.5\nWhen prescribed for an appropriate indication, CIPVISION KEYPROFEN 0.5 may offer the following benefits:\n- Anti-inflammatory action: Helps reduce inflammatory activity in selected ophthalmic conditions.\n- Management of eye pain: May relieve pain in specific clinical situations covered by the relevant product indication.\n- Non-steroidal treatment option: Provides an alternative mechanism to corticosteroid-based medicines for appropriate cases.\n- Local administration: Allows the active ingredient to be delivered directly to the eye.\n- Support for ophthalmic treatment: May be included in a treatment plan developed by an eye-care professional.\nThe response to treatment varies according to the diagnosis, severity of the condition, individual health factors, and adherence to the prescribed instructions. The product should not be considered a universal treatment for eye pain or inflammation.\nHow to Use CIPVISION KEYPROFEN 0.5 Eye Drops\nUse CIPVISION KEYPROFEN 0.5 only according to your ophthalmologist's instructions and the product leaflet.\n1. Clean your hands: Wash and dry your hands before handling the eye-drop bottle.\n2. Check the bottle: Confirm the product name, expiry date, and administration instructions before use.\n3. Prevent contamination: Keep the dropper tip away from your eyes, eyelids, fingers, and other surfaces.\n4. Follow the prescribed dosage: Use only the recommended number of drops and the prescribed frequency.\n5. Use other eye medicines carefully: Ask your healthcare professional how much time to leave between different ophthalmic preparations.\n6. Avoid prolonged use: Do not continue treatment longer than recommended, as extended NSAID use may increase the risk of eye complications.\n7. Follow storage instructions: Store the medicine as directed on its packaging and observe any instructions concerning use after opening.\n8. Do not share the bottle: Sharing eye drops can increase the risk of contamination.\n9. Attend follow-up appointments: Follow your ophthalmologist's advice, particularly when using the medicine after eye surgery.\nIf you miss a dose, follow the instructions in the product leaflet or consult your healthcare professional. Do not double the next dose to compensate for a missed application.\nPrecautions and Safety Information\nAlthough Ketorolac Tromethamine eye drops can be useful in appropriate clinical settings, they may cause side effects and require additional caution in certain patients.\nPossible Side Effects\nSome people may experience temporary burning, stinging, irritation, or discomfort after applying the drops. Ophthalmic NSAIDs can also delay healing and, in susceptible individuals, increase the risk of corneal complications. Rare cases of serious corneal damage have been reported.\n\nContact your ophthalmologist if symptoms persist or worsen. Seek urgent medical assessment if you experience severe eye pain, significant changes in vision, marked redness, or other serious symptoms.\nImportant Precautions\n- Corneal conditions: Tell your doctor if you have corneal disease, a damaged eye surface, or delayed healing.\n- Dry eyes: Inform your healthcare professional if you have severe dry eye symptoms or another condition affecting the eye surface.\n- Allergies: Disclose any previous allergic reaction to Ketorolac, aspirin, or other NSAIDs.\n- Bleeding risks: Discuss any bleeding disorder or medicine that may increase bleeding risk.\n- Eye surgery: Follow your surgeon's instructions, as postoperative use requires appropriate monitoring.\n- Pregnancy and breastfeeding: Consult your doctor before using the medicine during pregnancy or while breastfeeding.\n- Other medicines: Inform your healthcare professional about all medicines and eye preparations you currently use.\nCIPVISION KEYPROFEN 0.5 is intended for ophthalmic use only. Keep it out of children's reach and never use it beyond the labelled expiry date.\nWhy Consider CIPVISION KEYPROFEN 0.5 for Pharmaceutical Product Portfolios?\nCIPVISION KEYPROFEN 0.5 combines a distinct pharmaceutical brand identity with Ketorolac Tromethamine 0.5% ophthalmic solution. The formulation may be relevant to product catalogues serving pharmacies, medical distributors, and healthcare professionals involved in ophthalmic care.\n\nClear product information supports responsible pharmaceutical communication by explaining the active ingredient, its mechanism of action, appropriate clinical applications, and safety considerations.\n\nFor accurate product representation, always verify the approved strength, indications, contraindications, dosage, storage requirements, and instructions against the official packaging and prescribing information.\nConclusion\nCIPVISION KEYPROFEN 0.5 Eye Drops contains Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory ingredient used in selected ophthalmic conditions. By inhibiting prostaglandin production, it helps manage inflammation and may relieve pain in specific approved clinical settings.\n\nCorrect administration, appropriate patient selection, and awareness of potential side effects are essential for responsible use. Consult a qualified eye-care professional for treatment guidance and refer to the approved product information for complete details.\nFrequently Asked Questions (FAQs)\n1. What is CIPVISION KEYPROFEN 0.5?\nCIPVISION KEYPROFEN 0.5 is an ophthalmic solution containing Ketorolac Tromethamine 0.5% w/v, according to the composition provided. It is intended for specific eye-care applications under professional guidance.\n2. What is CIPVISION KEYPROFEN 0.5 used for?\nKetorolac Tromethamine ophthalmic preparations may be prescribed for certain inflammatory eye conditions, itching associated with seasonal allergic conjunctivitis, or pain and inflammation following specific eye procedures. The approved uses of CIPVISION KEYPROFEN 0.5 must be confirmed from its official product information.\n3. How does Ketorolac Tromethamine work in the eyes?\nKetorolac Tromethamine inhibits cyclooxygenase enzymes involved in prostaglandin production. This helps reduce inflammatory activity and associated pain in appropriate ophthalmic conditions.\n4. Can CIPVISION KEYPROFEN 0.5 be used without a prescription?\nUse this medicine only under appropriate medical guidance. An eye-care professional should determine whether it is suitable, particularly because NSAID eye drops can affect healing and may cause complications in susceptible patients.\n5. What precautions should be taken while using CIPVISION KEYPROFEN 0.5?\nAvoid contaminating the dropper tip, follow the prescribed dosage, and do not use the drops for longer than recommended. Inform your doctor about corneal problems, allergies to NSAIDs, bleeding disorders, and other medicines you use.\n6. How should CIPVISION KEYPROFEN 0.5 be stored?\nFollow the storage instructions on the product packaging. Keep the container closed as directed, protect it from unsuitable storage conditions, and observe any instructions concerning disposal after opening.\n\n\n",
"price": 80.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2503,
"imageuri": "https://productimages.withfloats.com/actual/6ad73c52dc6a6c6c9945f376.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad73c52dc6a6c6c9945f376.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:02:56.893Z",
"updatedon": "2026-10-20T10:02:56.893Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ophthalmic-solution/2503",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION KEYPROFEN 0.5",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}